Biogen (BIIB) option implied volatility increases
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) September weekly call option implied volatility is at 121, October is at 112; compared to its 52-week range of 29 to 97 into topline phase 3 data for Alzheimer's drug lecanemab.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) PT Raised to $245 at Piper Sandler
- Micron Technology (MU) call put ratio 1.9 calls to 1 put amid share price up 4.5%
- Western Digital (WDC) call put ratio 1.1 calls to 1 put as share price up 4.2%
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
